HC Wainwright Reiterates “Buy” Rating for Aldeyra Therapeutics (NASDAQ:ALDX)
HC Wainwright reissued their buy rating on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a research report released on Friday,Benzinga reports. HC Wainwright currently has a $10.00 price target on the biotechnology company’s stock. Aldeyra Therapeutics Trading Up 33.1 % ALDX stock opened at $1.89 on Friday. The company has a current ratio […]
HC Wainwright reissued their buy rating on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a research report released on Friday,Benzinga reports. HC Wainwright currently has a $10.00 price target on the biotechnology company’s stock. Aldeyra Therapeutics Trading Up 33.1 % ALDX stock opened at $1.89 on Friday. The company has a current ratio […]
